Plant ID: NPO11796
Plant Latin Name: Morus Australis
Taxonomy Genus: Morus
Taxonomy Family: Moraceae
NCBI TaxonomyDB:
66392
Plant-of-the-World-Online:
n.a.
Anthelmintic; Aromatic; Astringent; Febrifuge; Laxative; Purgative
India; Indonesia; China; Vietnam
Ingredient ID: NPC99486
Ingredient ID: NPC96565
Ingredient ID: NPC9440
Ingredient ID: NPC91216
Ingredient ID: NPC83264
Ingredient ID: NPC81805
Ingredient ID: NPC79417
Ingredient ID: NPC77856
Ingredient ID: NPC75643
Ingredient ID: NPC6875
Ingredient ID: NPC6527
Ingredient ID: NPC65043
Ingredient ID: NPC63743
Ingredient ID: NPC62840
Ingredient ID: NPC61872
Ingredient ID: NPC61533
Ingredient ID: NPC5441
Ingredient ID: NPC51265
Ingredient ID: NPC50413
Ingredient ID: NPC50125
Ingredient ID: NPC478516
Ingredient ID: NPC478515
Ingredient ID: NPC478514
Ingredient ID: NPC478513
Ingredient ID: NPC478512
Ingredient ID: NPC478511
Ingredient ID: NPC475799
Ingredient ID: NPC474397
Ingredient ID: NPC46446
Ingredient ID: NPC45940
Ingredient ID: NPC40065
Ingredient ID: NPC39488
Ingredient ID: NPC36363
Ingredient ID: NPC35802
Ingredient ID: NPC349899
Ingredient ID: NPC33259
Ingredient ID: NPC311422
Ingredient ID: NPC311219
Ingredient ID: NPC309135
Ingredient ID: NPC306215
Ingredient ID: NPC299703
Ingredient ID: NPC29890
Ingredient ID: NPC29864
Ingredient ID: NPC294836
Ingredient ID: NPC294494
Ingredient ID: NPC293053
Ingredient ID: NPC290443
Ingredient ID: NPC285881
Ingredient ID: NPC285265
Ingredient ID: NPC284238
Ingredient ID: NPC281768
Ingredient ID: NPC276738
Ingredient ID: NPC275148
Ingredient ID: NPC273820
Ingredient ID: NPC271977
Ingredient ID: NPC271298
Ingredient ID: NPC270831
Ingredient ID: NPC270569
Ingredient ID: NPC269429
Ingredient ID: NPC267727
Ingredient ID: NPC266940
Ingredient ID: NPC266712
Ingredient ID: NPC26574
Ingredient ID: NPC26431
Ingredient ID: NPC261405
Ingredient ID: NPC259315
Ingredient ID: NPC257421
Ingredient ID: NPC253165
Ingredient ID: NPC253090
Ingredient ID: NPC248182
Ingredient ID: NPC243860
Ingredient ID: NPC241081
Ingredient ID: NPC23765
Ingredient ID: NPC236709
Ingredient ID: NPC235292
Ingredient ID: NPC229622
Ingredient ID: NPC228433
Ingredient ID: NPC226169
Ingredient ID: NPC225665
Ingredient ID: NPC225507
Ingredient ID: NPC224651
Ingredient ID: NPC223461
Ingredient ID: NPC218410
Ingredient ID: NPC217763
Ingredient ID: NPC217083
Ingredient ID: NPC216333
Ingredient ID: NPC216267
Ingredient ID: NPC216081
Ingredient ID: NPC214535
Ingredient ID: NPC211579
Ingredient ID: NPC208486
Ingredient ID: NPC201856
Ingredient ID: NPC201399
Ingredient ID: NPC193238
Ingredient ID: NPC189130
Ingredient ID: NPC189087
Ingredient ID: NPC186422
Ingredient ID: NPC177676
Ingredient ID: NPC176874
Ingredient ID: NPC175308
Ingredient ID: NPC165122
Ingredient ID: NPC163021
Ingredient ID: NPC159789
Ingredient ID: NPC152195
Ingredient ID: NPC14208
Ingredient ID: NPC135046
Ingredient ID: NPC133922
Ingredient ID: NPC132840
Ingredient ID: NPC125575
Ingredient ID: NPC118736
Ingredient ID: NPC108896
Ingredient ID: NPC105224
Ingredient ID: NPC103267
Ingredient ID: NPC102759
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 2 | CYP2B6 | Cytochrome P450 2B6 | P20813 | CHEMBL4729 |
Therapeutic Target | Enzyme | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Phosphodiesterase 4 | PDE4D | Phosphodiesterase 4D | Q08499 | CHEMBL288 |
Therapeutic Target | Small molecule receptor (family A GPCR) | PTAFR | Platelet activating factor receptor | P25105 | CHEMBL250 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 355 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT03170115 | Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | rectum cancer | Aspirin (NPC311219) | NP level |
NCT00300365 | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL | metabolic syndrome | Aspirin (NPC311219) | NP level |
NCT02224131 | Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling | stroke | Aspirin (NPC311219) | NP level |
NCT01675115 | Efficacy of BNG-1 to Treat Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02217501 | Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT02929888 | Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients | acute myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02427126 | Apixaban for Treatment of Embolic Stroke of Undetermined Source | stroke | Aspirin (NPC311219) | NP level |
NCT02072226 | A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT02439190 | CV004-007 Thrombosis Chamber Study | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT05428072 | Alcohol, Gut Leakiness, & Liver Disease | alcoholic liver disease | Aspirin (NPC311219) | NP level |
NCT02895113 | Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT02260622 | Pilot Study to Examine the Use of Rivaroxaban After Angioplasty for Critical Limb Ischemia | ischemia | Aspirin (NPC311219) | NP level |
NCT02158806 | Low Dose Aspirin for Venous Leg Ulcers | varicose ulcer | Aspirin (NPC311219) | NP level |
NCT01245608 | Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables. | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02071004 | DS1040b/Aspirin Drug/Drug Interaction Study | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT03063541 | Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms | brain aneurysm | Aspirin (NPC311219) | NP level |
NCT02951533 | A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis | psoriasis | Fumaric Acid (NPC224651) | NP level |
NCT03765619 | Postoperative Aspirin and Ankle Fracture Healing | bone fracture | Aspirin (NPC311219) | NP level |
NCT02323516 | Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies. | cancer | Aspirin (NPC311219) | NP level |
NCT03532698 | Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT04588727 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT03225352 | A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets | pain | Aspirin (NPC311219) | NP level |
NCT01486433 | The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects | Hypertriglyceridemia | Aspirin (NPC311219) | NP level |
NCT02433587 | Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT04214990 | Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients | gastric cancer | Aspirin (NPC311219) | NP level |
NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT01431053 | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | breast neoplasm | Aspirin (NPC311219) | NP level |
NCT04860804 | A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain | pain | Aspirin (NPC311219) | NP level |
NCT01831011 | Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00501059 | A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01633528 | The Effect of Low Dose Aspirin in Increasing the Chance of Pregnancy | infertility | Aspirin (NPC311219) | NP level |
NCT03197779 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT04229264 | Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. | ischemia | Aspirin (NPC311219) | NP level |
NCT02326779 | Low-dose Aspirin Therapy for Esophageal Cancer | esophageal cancer | Aspirin (NPC311219) | NP level |
NCT02174328 | Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes. | preeclampsia | Aspirin (NPC311219) | NP level |
NCT02596126 | Secondary Prevention of Cardiovascular Disease in the Elderly Trial | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT04535804 | Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery | endometriosis of uterus | Aspirin (NPC311219) | NP level |
NCT02674958 | Mobilization of Endothelial Progenitor Cells and Aspirin | hypertrophic cardiomyopathy | Aspirin (NPC311219) | NP level |
NCT02984384 | PREVENTion of Clot in Orthopaedic Trauma | injury;thrombotic disease | Aspirin (NPC311219) | NP level |
NCT00626392 | Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
NCT00223717 | Treatment of Supine Hypertension in Autonomic Failure | hypertension | Aspirin (NPC311219) | NP level |
NCT00797056 | Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease | peripheral vascular disease | Aspirin (NPC311219) | NP level |
NCT03316534 | Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
NCT02239120 | Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) | stroke | Aspirin (NPC311219) | NP level |
NCT01429272 | Minocycline and Aspirin in the Treatment of Bipolar Depression | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT02548650 | Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT01800357 | Efficacy and Safety of Mildronate for Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00405613 | Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population | hemorrhage | Aspirin (NPC311219) | NP level |
NCT02497820 | Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT02906761 | Aspirin for Uncontrolled Asthma | asthma | Aspirin (NPC311219) | NP level |
NCT03459560 | Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT00000152 | Randomized Trial of Beta-Carotene and Macular Degeneration | macular degeneration | Aspirin (NPC311219) | NP level |
NCT01739556 | On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00000510 | Platelet-Inhibitor Drug Trial in Coronary Angioplasty | angina pectoris;Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT03794596 | A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT00578721 | Trial of Aspirin and Arginine Restriction in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02671461 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT02798913 | Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT04070573 | Low Doses of Aspirin in the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT00055731 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | prostate cancer | Aspirin (NPC311219) | NP level |
NCT04160546 | Study to Evaluate the Reinduction and Second Stop of TKI With Ponatinib in CML in Molecular Response (ResToP) | chronic myelogenous leukemia | Aspirin (NPC311219) | NP level |
NCT01646814 | Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects | duodenal ulcer | Aspirin (NPC311219) | NP level |
NCT02333123 | Aspirin for Venous Ulcers: Randomised Trial (AVURT) | varicose ulcer | Aspirin (NPC311219) | NP level |
NCT02677545 | Ticagrelor Versus Clopidogrel in Carotid Artery Stenting | internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
NCT01504867 | LIPS-A: Lung Injury Prevention Study With Aspirin | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
NCT02685748 | Aspirin in Young Psychotic Patients | schizophrenia | Aspirin (NPC311219) | NP level |
NCT02183688 | Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients | migraine disorder | Aspirin (NPC311219) | NP level |
NCT04128956 | Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS | Venous thrombosis | Aspirin (NPC311219) | NP level |
NCT03341117 | Acetylsalicylic Acid and Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT00331786 | Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04188119 | A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT05491200 | Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02834403 | L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients | breast cancer | Aspirin (NPC311219) | NP level |
NCT02869009 | Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT04363840 | The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations | blood coagulation disease;Disseminated intravascular coagulation;vitamin D deficiency;COVID-19 | Aspirin (NPC311219) | NP level |
NCT05265299 | Trial to Determine Effective Aspirin Dose in COPD | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT02419820 | Dose-escalation, Repeated and Single Oral Dosing Study | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT01720108 | Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT01707823 | Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer | lung adenocarcinoma | Aspirin (NPC311219) | NP level |
NCT00062023 | Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | cancer | Aspirin (NPC311219) | NP level |
NCT00261586 | A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach | pain | Aspirin (NPC311219) | NP level |
NCT00727948 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | breast cancer | Aspirin (NPC311219) | NP level |
NCT00566904 | New Topical Treatment for Continued Pain After Shingles | postherpetic neuralgia | Aspirin (NPC311219) | NP level |
NCT04410328 | Aggrenox To Treat Acute Covid-19 | COVID-19 | Aspirin (NPC311219) | NP level |
NCT01459627 | Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02989558 | A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI | aortic stenosis | Aspirin (NPC311219) | NP level |
NCT00000479 | Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | cerebrovascular disorder;Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00000469 | Asymptomatic Carotid Artery Plaque Study (ACAPS) | heart disease;internal carotid artery stenosis;cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
NCT01046942 | ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery | thrombophilia;thrombotic disease | Aspirin (NPC311219) | NP level |
NCT01733485 | Electrophilic Fatty Acid Derivatives in Asthma | asthma | Aspirin (NPC311219) | NP level |
NCT00316927 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
NCT01802775 | Edoxaban in Peripheral Arterial Disease | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT00175032 | A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin | osteoarthritis;Peptic ulcer | Aspirin (NPC311219) | NP level |
NCT00000151 | Early Treatment Diabetic Retinopathy Study (ETDRS) | Blindness;diabetic retinopathy | Aspirin (NPC311219) | NP level |
NCT01515657 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT00238667 | To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection | stroke | Aspirin (NPC311219) | NP level |
NCT00263211 | A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | breast neoplasm | Aspirin (NPC311219) | NP level |
NCT02007837 | Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial | preeclampsia | Aspirin (NPC311219) | NP level |
NCT04142125 | Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT01496521 | Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols | squamous cell carcinoma | Aspirin (NPC311219) | NP level |
NCT03541109 | A Polypill for Secondary Prevention of Ischemic Heart Disease | Non-ST Elevation Myocardial Infarction;ST Elevation Myocardial Infarction;acute myocardial infarction | Aspirin (NPC311219) | NP level |
NCT04153760 | Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT01313702 | Single Pill to Avert Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01790997 | Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02647099 | Adjuvant Low Dose Aspirin in Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04381936 | Randomised Evaluation of COVID-19 Therapy | severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
NCT01796951 | Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
NCT04295486 | Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT01709994 | Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients | chronic kidney disease | Aspirin (NPC311219) | NP level |
NCT03787927 | Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets | hemorrhage | Aspirin (NPC311219) | NP level |
NCT02602938 | Aspirin on CTCs of Advanced Breast and Colorectal Cancer | neoplasm | Aspirin (NPC311219) | NP level |
NCT01271985 | Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02578706 | Targeting Platelets in Chronic HIV Infection | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT02126657 | The Efficacy and Safety of a Single 70% Glycolic Acid Peel With Vitamin C for the Treatment of Acne Scars | acne | Glycolic Acid (NPC165122) | NP level |
NCT00961350 | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
NCT02960126 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT03051646 | Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis | Fatigue | Aspirin (NPC311219) | NP level |
NCT05362500 | Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma | freckles | Glycolic Acid (NPC165122) | NP level |
NCT02047539 | Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis | psychosis | Aspirin (NPC311219) | NP level |
NCT00269438 | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis | ulcerative colitis | Aspirin (NPC311219) | NP level |
NCT01012349 | Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache. | Tension-type headache | Aspirin (NPC311219) | NP level |
NCT02666742 | DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation | stroke | Aspirin (NPC311219) | NP level |
NCT05233124 | Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT02966119 | REstart or STop Antithrombotic Randomised Trial in France | hemorrhage | Aspirin (NPC311219) | NP level |
NCT00935506 | Ex Vivo Human Thrombosis Chamber Study | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02474082 | Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. | psoriasis | Fumaric Acid (NPC224651) | NP level |
NCT01422109 | Comparative Pharmacokinetics of YH14659 | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT04860713 | An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache | pain | Aspirin (NPC311219) | NP level |
NCT03219645 | Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT05073718 | SARS-CoV-2 and Acetylsalicylic Acid (SARA) | COVID-19 | Aspirin (NPC311219) | NP level |
NCT02675205 | Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm | brain aneurysm | Aspirin (NPC311219) | NP level |
NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Aspirin (NPC311219) | NP level |
NCT04145258 | Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
NCT03487406 | Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT04535518 | Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
NCT04066725 | Aspirin as an Ultraviolet (UV) Protectant in Human Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT05056896 | ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT00027066 | Warfarin Versus Aspirin Recurrent Stroke Study | stroke | Aspirin (NPC311219) | NP level |
NCT01028079 | Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain | Low back pain | Aspirin (NPC311219) | NP level |
NCT01453400 | Evaluate the Time of Pain Relief of Fast Acting Aspirin Versus Acetaminophen in Subjects Diagnosed With Sore Throat Pain | pharyngitis | Aspirin (NPC311219) | NP level |
NCT02348203 | Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers | nicotine dependence | Aspirin (NPC311219) | NP level |
NCT02081638 | Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study | HIV infection | Aspirin (NPC311219) | NP level |
NCT00960869 | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | gastric ulcer | Aspirin (NPC311219) | NP level |
NCT04343001 | Coronavirus Response - Active Support for Hospitalised Covid-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
NCT00000527 | Recurrent Carotid Stenosis | heart disease;internal carotid artery stenosis | Aspirin (NPC311219) | NP level |
NCT02183220 | Efficacy and Tolerability of Metamizol in Patients With Episodic Moderate Headache | migraine disorder | Aspirin (NPC311219) | NP level |
NCT03093246 | Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
NCT01552798 | Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache | Headache | Aspirin (NPC311219) | NP level |
NCT00697021 | Thromboelastography As An Assessment Tool for Possible Clopidogrel and Aspirin Resistance | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT03152409 | Salicylic Augmentation in Depression | major depressive disorder;treatment resistant depression | Aspirin (NPC311219) | NP level |
NCT04078568 | Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease | mucocutaneous lymph node syndrome | Aspirin (NPC311219) | NP level |
NCT03377543 | Sleep and Inflammatory Resolution Pathway | inflammation | Aspirin (NPC311219) | NP level |
NCT00276380 | A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT01797575 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT02634801 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment | psoriasis | Fumaric Acid (NPC224651) | NP level |
NCT00061373 | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT02770274 | Cilostazol Following Peripheral Endovascular Procedures | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
NCT01659307 | The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury | acute lung injury | Aspirin (NPC311219) | NP level |
NCT01616615 | Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation | placental insufficiency | Aspirin (NPC311219) | NP level |
NCT00335452 | Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT04754789 | Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI | ST Elevation Myocardial Infarction | Aspirin (NPC311219) | NP level |
NCT01238185 | Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | Oral leukoplakia | Aspirin (NPC311219) | NP level |
NCT00684515 | Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005 | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT02326350 | ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial | acute respiratory distress syndrome | Aspirin (NPC311219) | NP level |
NCT01629329 | Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT00041938 | Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial | myocardial infarction;stroke | Aspirin (NPC311219) | NP level |
NCT00486512 | Chemoprevention of Colorectal Adenomas | Familial adenomatous polyposis | Aspirin (NPC311219) | NP level |
NCT03661411 | Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT00959621 | Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion | habitual abortion | Aspirin (NPC311219) | NP level |
NCT04937088 | Outpatient Liquid Aspirin (OLA) | COVID-19 | Aspirin (NPC311219) | NP level |
NCT01082874 | PeriOperative ISchemic Evaluation-2 Trial | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT04330872 | An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke. | stroke | Aspirin (NPC311219) | NP level |
NCT00587496 | 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers | Herpes simplex infection | Aspirin (NPC311219) | NP level |
NCT04554433 | New Treatment for COVID-19 Using Ethanol Vapor Inhalation . | COVID-19 | Aspirin (NPC311219) | NP level |
NCT01657071 | Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | cervical cancer;endometrial cancer | Aspirin (NPC311219) | NP level |
NCT01051778 | Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome | habitual abortion | Aspirin (NPC311219) | NP level |
NCT01936233 | Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | hepatocellular carcinoma | Aspirin (NPC311219) | NP level |
NCT00202020 | Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT01033526 | Symptomatic Treatment of Common Cold Symptoms | common cold | Aspirin (NPC311219) | NP level |
NCT04240834 | Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00000157 | Randomized Trial of Aspirin and Cataracts in U.S. Physicians | cataract | Aspirin (NPC311219) | NP level |
NCT04243278 | Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC) | preeclampsia | Aspirin (NPC311219) | NP level |
NCT04402385 | Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE) | preeclampsia | Aspirin (NPC311219) | NP level |
NCT03186456 | Human Umbilical Cord Mesenchymal Stem Cell Therapy (19 | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT03899987 | Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | prostate adenocarcinoma | Aspirin (NPC311219) | NP level |
NCT02341638 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT00384865 | A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC | ovarian cancer | Aspirin (NPC311219) | NP level |
NCT05122455 | Effects of Edoxaban on Platelet Aggregation | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT05035316 | Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT) | bipolar disorder | Aspirin (NPC311219) | NP level |
NCT00425074 | Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism. | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT01973205 | Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT00623779 | Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT01294462 | Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT02370680 | Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02965703 | Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | colorectal adenoma | Aspirin (NPC311219) | NP level |
NCT01248468 | Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine | migraine disorder | Aspirin (NPC311219) | NP level |
NCT02813824 | Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT04284397 | Identification of Critical Thermal Environments for Aged Adults | aging | Aspirin (NPC311219) | NP level |
NCT01211925 | Distal Venous Arterialisation of Ischemic Limb | ischemia | Aspirin (NPC311219) | NP level |
NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT00653172 | Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia | pneumonia | Aspirin (NPC311219) | NP level |
NCT04498273 | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | COVID-19 | Aspirin (NPC311219) | NP level |
NCT00000491 | Aspirin-Myocardial Infarction Study (AMIS) | Myocardial Ischemia;myocardial infarction | Aspirin (NPC311219) | NP level |
NCT00998075 | Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
NCT02164864 | BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT03047837 | A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT00790452 | Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma | glioblastoma multiforme | Aspirin (NPC311219) | NP level |
NCT01426438 | Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | COVID-19 | Aspirin (NPC311219) | NP level |
NCT00814268 | COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT02293395 | A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT05036109 | DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease | colorectal carcinoma;malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT02545933 | Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT02832531 | INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority | rheumatic heart disease | Aspirin (NPC311219) | NP level |
NCT01768637 | Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study | chronic kidney disease | Aspirin (NPC311219) | NP level |
NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | COVID-19 | Aspirin (NPC311219) | NP level |
NCT01015729 | Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately | peptic ulcer disease | Aspirin (NPC311219) | NP level |
NCT02164578 | Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Cardiovascular Disease | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT02776540 | Clopidogrel for Acute Ischaemia of Recent Onset | stroke | Aspirin (NPC311219) | NP level |
NCT00311402 | JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme | stroke | Aspirin (NPC311219) | NP level |
NCT04038489 | COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer | breast cancer | Aspirin (NPC311219) | NP level |
NCT01355705 | Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT00000496 | Platelet Drug Trial in Coronary Disease Progression | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT01784159 | ASpirin for Patients With SEPsis and SeptIc Shock | Sepsis | Aspirin (NPC311219) | NP level |
NCT00235248 | Aortic Arch Related Cerebral Hazard Trial (ARCH) | brain infarction;transient ischemic attack | Aspirin (NPC311219) | NP level |
NCT05035277 | AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation | aortic stenosis | Aspirin (NPC311219) | NP level |
NCT00482261 | A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT01328145 | Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease | chronic obstructive pulmonary disease | Aspirin (NPC311219) | NP level |
NCT02812719 | Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel | freckles | Glycolic Acid (NPC165122) | NP level |
NCT02689037 | Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis | cerebral atherosclerosis | Aspirin (NPC311219) | NP level |
NCT03957902 | Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02659384 | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer | ovarian neoplasm | Aspirin (NPC311219) | NP level |
NCT03396952 | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT02927249 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | breast cancer | Aspirin (NPC311219) | NP level |
NCT01994720 | [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES] | stroke | Aspirin (NPC311219) | NP level |
NCT01103440 | Aspirin Resistance and Percutaneous Coronary Intervention (PCI) | angina pectoris | Aspirin (NPC311219) | NP level |
NCT00178464 | Aspirin Prophylaxis in Sickle Cell Disease | sickle cell anemia | Aspirin (NPC311219) | NP level |
NCT00496769 | A Phase III Study of Apixaban in Patients With Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT01518231 | Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT03405974 | Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip | osteonecrosis | Aspirin (NPC311219) | NP level |
NCT01762787 | Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers | inflammation | Aspirin (NPC311219) | NP level |
NCT01526122 | Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration | atherosclerosis | Aspirin (NPC311219) | NP level |
NCT04962451 | Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT05308030 | Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT04182100 | Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | essential thrombocythemia;polycythemia vera | Aspirin (NPC311219) | NP level |
NCT03578822 | Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial | stroke | Aspirin (NPC311219) | NP level |
NCT00915733 | Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT05105919 | Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT03824938 | Aspirin for Exercise in Multiple Sclerosis (ASPIRE) | multiple sclerosis | Aspirin (NPC311219) | NP level |
NCT01352988 | Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | cutaneous lupus erythematosus | Fumaric Acid (NPC224651) | NP level |
NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | COVID-19;severe acute respiratory syndrome | Aspirin (NPC311219) | NP level |
NCT00940784 | Clopidogrel and Aspirin for the Treatment of Polycythemia Vera | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT02301286 | A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT02797249 | Low Dose Aspirin in the Prevention of Preeclampsia in China | preeclampsia | Aspirin (NPC311219) | NP level |
NCT03464305 | ASPIRIN Trial Belgium | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT00417898 | Study of Aspirin and TPA in Acute Ischemic Stroke | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT00004728 | Aspirin Or Warfarin To Prevent Stroke | atherosclerosis;cerebral infarction;stroke | Aspirin (NPC311219) | NP level |
NCT02271399 | Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty | venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT04526951 | TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) | retinal artery occlusion | Aspirin (NPC311219) | NP level |
NCT02945033 | Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT04575519 | Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis | tuberculosis | Aspirin (NPC311219) | NP level |
NCT04557475 | Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction | fetal growth restriction | Aspirin (NPC311219) | NP level |
NCT03480776 | ASA in Prevention of Ovarian Cancer (STICs and STONEs) | ovarian cancer | Aspirin (NPC311219) | NP level |
NCT00833833 | MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT00644085 | Does Low-Dose Aspirin Improve Outcome in In Vitro Fertilisation/Intra Cytoplasmatic Sperm Injection (IVF/ICSI)? | infertility | Aspirin (NPC311219) | NP level |
NCT01635426 | Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages | pregnancy | Aspirin (NPC311219) | NP level |
NCT04379999 | Atorvastatin ± Aspirin in Lynch Syndrome Syndrome | Lynch syndrome | Aspirin (NPC311219) | NP level |
NCT01057537 | UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT04062032 | Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma | cutaneous melanoma | Aspirin (NPC311219) | NP level |
NCT03245489 | Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Aspirin (NPC311219) | NP level |
NCT00105209 | A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension | pulmonary arterial hypertension | Aspirin (NPC311219) | NP level |
NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | malignant colon neoplasm | Aspirin (NPC311219) | NP level |
NCT01362218 | Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol | Hypercholesterolemia | Aspirin (NPC311219) | NP level |
NCT00265408 | Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT01661322 | Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke | stroke | Aspirin (NPC311219) | NP level |
NCT02313909 | Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) | stroke | Aspirin (NPC311219) | NP level |
NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT03056703 | Bioequivalence of Single Dose Fast Release Aspirin (1000 mg) Tablet Versus Single Dose of Two 500 mg Fast Release Aspirin Tablets | pain | Aspirin (NPC311219) | NP level |
NCT03543683 | Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT01890005 | Low Dose Aspirin for the Prevention of Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT00004727 | Antiplatelet Therapy to Prevent Stroke in African Americans | stroke | Aspirin (NPC311219) | NP level |
NCT00562588 | EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA | stroke | Aspirin (NPC311219) | NP level |
NCT02607072 | Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT00963443 | Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold | common cold | Aspirin (NPC311219) | NP level |
NCT00357682 | A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia | esophageal cancer | Aspirin (NPC311219) | NP level |
NCT01321164 | Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis | psoriasis | Fumaric Acid (NPC224651) | NP level |
NCT00783614 | Aspirin and Antiretroviral Therapy in HIV Infected Patients | HIV infection | Aspirin (NPC311219) | NP level |
NCT03927313 | Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM | meningitis | Aspirin (NPC311219) | NP level |
NCT00631111 | Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental Pain | pain | Aspirin (NPC311219) | NP level |
NCT00731302 | Aspirin Resistance in Systemic Lupus Erythematosus (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
NCT00244426 | S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT03667326 | Postpartum Low-Dose Aspirin and Preeclampsia | preeclampsia | Aspirin (NPC311219) | NP level |
NCT03176498 | MK-5348-017) | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT00059306 | Secondary Prevention of Small Subcortical Strokes Trial | stroke | Aspirin (NPC311219) | NP level |
NCT00000161 | Randomized Trials of Vitamin Supplements and Eye Disease | cataract;macular degeneration | Aspirin (NPC311219) | NP level |
NCT01755520 | Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG | acute coronary syndrome;angina pectoris | Aspirin (NPC311219) | NP level |
NCT00054938 | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) | systemic lupus erythematosus | Aspirin (NPC311219) | NP level |
NCT02227368 | Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR | peripheral arterial disease | Aspirin (NPC311219) | NP level |
NCT03961334 | MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention | stroke | Aspirin (NPC311219) | NP level |
NCT00776477 | The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease | atherosclerosis | Aspirin (NPC311219) | NP level |
NCT04792723 | Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet | cardiovascular disease | Aspirin (NPC311219) | NP level |
NCT02034292 | Safety Study of APD-791 With Aspirin and/or Clopidogrel | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT02062255 | Impact of COX2 on Sera Biomarkers From Obese Subjects | breast cancer | Aspirin (NPC311219) | NP level |
NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | Gastrointestinal hemorrhage | Aspirin (NPC311219) | NP level |
NCT05156879 | Aspirin for the Management of Endometriosis-associated Pelvic Pain | pain | Aspirin (NPC311219) | NP level |
NCT04809818 | A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects | Ischemic stroke | Aspirin (NPC311219) | NP level |
NCT01320982 | Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder | schizoaffective disorder;schizophrenia | Aspirin (NPC311219) | NP level |
NCT00775762 | Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events | vascular disease | Aspirin (NPC311219) | NP level |
NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | prostate cancer | Aspirin (NPC311219) | NP level |
NCT00007683 | Warfarin and Antiplatelet Therapy in Chronic Heart Failure | heart failure | Aspirin (NPC311219) | NP level |
NCT03197194 | A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion | retinal artery occlusion | Aspirin (NPC311219) | NP level |
NCT00129805 | Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) | cerebral infarction | Aspirin (NPC311219) | NP level |
NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | respiratory failure;viral pneumonia;COVID-19;venous thromboembolism | Aspirin (NPC311219) | NP level |
NCT02420652 | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy | prostate carcinoma | Aspirin (NPC311219) | NP level |
NCT02125409 | Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT02155985 | Modulation of Immune Activation by Aspirin | HIV-1 infection | Aspirin (NPC311219) | NP level |
NCT01741922 | Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients | hypertension | Aspirin (NPC311219) | NP level |
NCT01985321 | Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores | Herpes Labialis | Glycolic Acid (NPC165122) | NP level |
NCT02846532 | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure | thrombotic disease | Aspirin (NPC311219) | NP level |
NCT00630877 | Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin | Disorder of lipid metabolism | Aspirin (NPC311219) | NP level |
NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer | non-small cell lung carcinoma | Aspirin (NPC311219) | NP level |
NCT00000500 | Physicians' Health Study | Myocardial Ischemia | Aspirin (NPC311219) | NP level |
NCT01321255 | Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. | myocardial infarction | Aspirin (NPC311219) | NP level |
NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | breast cancer | Aspirin (NPC311219) | NP level |
NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT04645004 | Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy | preeclampsia | Aspirin (NPC311219) | NP level |
NCT02301780 | Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention | preeclampsia | Aspirin (NPC311219) | NP level |
NCT02120092 | The Effect of Clopidogrel and Ticagrelor With and Without Acetylsalicylic Acid (ASA) on Hemostatic System Activation at the Site of Plug Formation in Vivo in Man | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00732927 | Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion | retinal vein occlusion | Aspirin (NPC311219) | NP level |
NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039 | atrial fibrillation | Aspirin (NPC311219) | NP level |
NCT00910065 | BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) | acute coronary syndrome | Aspirin (NPC311219) | NP level |
NCT00405756 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT03820466 | Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin | acute chest syndrome | Aspirin (NPC311219) | NP level |
NCT04824911 | Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease | stroke | Aspirin (NPC311219) | NP level |
NCT04649203 | Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy | diabetic neuropathy | Succinic Acid (NPC236709) | NP level |
NCT02268565 | Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms | insomnia | Aspirin (NPC311219) | NP level |
NCT03428373 | Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
NCT03574909 | IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes | diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT03003325 | The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV | polycythemia vera | Aspirin (NPC311219) | NP level |
NCT02521285 | Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation | Barrett's esophagus | Aspirin (NPC311219) | NP level |
NCT02237365 | A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis | meningitis | Aspirin (NPC311219) | NP level |
NCT02008942 | Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients | type 2 diabetes mellitus | Aspirin (NPC311219) | NP level |
NCT03093207 | Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis | periodontitis | Aspirin (NPC311219) | NP level |
NCT03103152 | A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression | prostate cancer | Aspirin (NPC311219) | NP level |
NCT00002527 | Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Aspirin (NPC311219) | NP level |
NCT03290820 | Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | nasopharyngeal neoplasm | Aspirin (NPC311219) | NP level |
NCT00688428 | Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination | gastrointestinal disease;ulcer disease | Aspirin (NPC311219) | NP level |
NCT00872534 | Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers | gastrointestinal disease | Aspirin (NPC311219) | NP level |
NCT01042704 | Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | multiple myeloma | Aspirin (NPC311219) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
PTGS1
NCT04860713,NCT00261586,NCT03225352,NCT05156879,NCT03056703,NCT04860804,NCT00631111 |
Chronic arterial occlusive disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
NCT02227368,NCT02217501,NCT01802775,NCT02798913,NCT02433587,NCT00797056,NCT02770274,NCT05308030
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
NCT03491410,NCT02834403,NCT02927249,NCT00727948,NCT04038489,NCT02062255,NCT04188119,NCT03794596
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT02341638,NCT02439190,NCT03197779,NCT02846532,NCT02671461,NCT01046942,NCT02984384
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT01355705,NCT00833833,NCT00258245,NCT01042704,NCT00482261,NCT00405756,NCT03428373
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CYP2B6,LMNA,BLM,PTAFR,PTGS1,PDE4D,NAPRT
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
PDE4D,PTAFR
NCT01321164,NCT02634801,NCT02951533,NCT02474082 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PTGS1
NCT02008942,NCT02164578,NCT05105919,NCT01515657,NCT03341117 |
Cerebral ischaemic stroke, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11.5Z |
NCT00129805,NCT03176498,NCT03186456,NCT00004728,NCT00684515,NCT00202020
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT00244426,NCT01830543,NCT00623779,NCT02164864,NCT00496769,NCT02960126
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT03047837,NCT03464305,NCT02301286,NCT02467582,NCT05036109
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT01629329,NCT01973205,NCT01248468,NCT02183220,NCT02183688
|
Polycythaemia veraDisease Category: X.Extension CodesDisease ICD-11 Code: XH0453 |
NCT01259856,NCT03003325,NCT00940784,NCT01259817,NCT04182100
|
Asymptomatic stenosis of intracranial or extracranial arteryDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD55 |
NCT00000469,NCT02677545,NCT00000527,NCT02689037,NCT00000469
|
Venous thromboembolismDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD72 |
NCT02271399,NCT04368377,NCT04153760,NCT01720108,NCT04295486
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT03377543,NCT01762787,NCT02497820,NCT04379999,NCT02813824
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT00000479,NCT00000491,NCT00000500,NCT00000510,NCT00000496
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LMNA,BLM,PTAFR,TSHR,PTGS1
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
PDE4D
NCT05265299,NCT01328145,NCT03487406 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
PTAFR,PDE4D
NCT02906761,NCT01733485 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT03103152,NCT03819101,NCT00055731,NCT00316927
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT01741922,NCT00105209,NCT00223717,NCT00384865
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03543683,NCT01058902,NCT03532698,NCT02387086
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
PTGS1,CYP2B6,TSHR,PTAFR
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
LMNA,BLM,PTAFR,PTGS1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
PTGS1,CYP2B6,BLM,PTAFR
|
Peptic ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61 |
NCT00998075,NCT01015729,NCT00175032
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT01797575,NCT05035316,NCT01429272
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
NCT01755520,NCT01103440,NCT00000510
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT04062032,NCT03396952,NCT04066725
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT00776477,NCT01526122,NCT00004728
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01426438,NCT02155985,NCT02578706
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT00405613,NCT02966119,NCT03787927
|
Other specified infectious meningitis not elsewhere classifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D01.Y |
NCT04145258,NCT03927313,NCT02237365
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
NCT04229264,NCT02260622,NCT01211925
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT03316534,NCT02081638,NCT00783614
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
PDE4D,BLM,PTGS1
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR,BLM,PTAFR
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
LMNA,BLM,TSHR
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
PTGS1,LMNA,PTAFR
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
CYP2B6,TSHR,BLM
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
PTAFR
NCT01518231,NCT00238667,NCT01994720,NCT03578822,NCT04824911,NCT02239120,NCT00311402,NCT00041938,NCT00814268,NCT02224131,NCT02313909,NCT00059306,NCT03192215,NCT02072226,NCT00027066,NCT04330872,NCT02666742,NCT00004728,NCT04962451,NCT02776540,NCT00562588,NCT03961334,NCT03661411,NCT00276380,NCT01661322,NCT02427126,NCT00004727 |
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
PTGS1,PTAFR
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
PTAFR
NCT02984384 |
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
PDE4D,PTGS1
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
PTGS1,PDE4D
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
PTGS1,PDE4D
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
PTGS1
NCT00269438 |
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
PTGS1
NCT04575519 |
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
PTAFR
NCT01784159 |
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
PDE4D,PTGS1
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
PTGS1
NCT00175032 |
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT03480776,NCT03378297
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00000527,NCT00000469
|
Recurrent pregnancy lossDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA33 |
NCT01051778,NCT00959621
|
Male infertilityDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB04 |
NCT00644085,NCT01633528
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NCT02895113,NCT03574909
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT03541109,NCT02929888
|
Tension-type headacheDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A81 |
NCT01552798,NCT01012349
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT01504867,NCT02326350
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT00357682,NCT02326779
|
Mucocutaneous lymph node syndromeDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44.5 |
NCT04078568,NCT04535518
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
NCT00731302,NCT00054938
|
Retinal artery occlusionsDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74.0 |
NCT04526951,NCT03197194
|
Periodontal diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0C |
NCT03093246,NCT03093207
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT03541109,NCT04754789
|
Aortic valve stenosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB70 |
NCT05035277,NCT02989558
|
FrecklesDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED61.0 |
NCT05362500,NCT02812719
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04381936,NCT04324463
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT02685748,NCT01320982
|
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
NCT00626392,NCT00630877
|
Cerebral aneurysm, nonrupturedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22.5 |
NCT03063541,NCT02675205
|
Venous leg ulcer, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD74.3Z |
NCT02333123,NCT02158806
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00872534,NCT00688428
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT02285738,NCT02323516
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT00263211,NCT01431053
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT01709994,NCT01768637
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
NCT01259856,NCT01259817
|
Common cold disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SA60 |
NCT01033526,NCT00963443
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT00000152,NCT00000161
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT01796951,NCT02348203
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02735707,NCT00653172
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
NCT00000157,NCT00000161
|
Gastric ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA60 |
NCT00960869,NCT00961350
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
TSHR,PTAFR
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TSHR,BLM
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CYP2B6,BLM
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CYP2B6,BLM
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
PDE4D,PTAFR
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CYP2B6,BLM
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CYP2B6,BLM
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
PDE4D,PTAFR
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
PDE4D,BLM
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
BLM,PTGS1
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
PTGS1
NCT02545933,NCT01739556,NCT02548650,NCT00000479,NCT00041938,NCT00000491,NCT05491200,NCT05122455,NCT01459627,NCT02596126,NCT01321255,NCT00915733,NCT00697021 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
PTGS1
NCT02607072,NCT02647099,NCT00062023,NCT00578721,NCT00565708,NCT02945033,NCT05036109,NCT03957902,NCT00331786,NCT00002527,NCT02965703,NCT05056896,NCT02125409 |
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PTGS1
NCT04588727,NCT00425074,NCT01245608,NCT01271985,NCT00935506,NCT01082874,NCT04792723,NCT01057537,NCT00501059,NCT02370680,NCT01313702,NCT03459560 |
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT02419820,NCT01422109,NCT00699998,NCT01657071,NCT04240834,NCT00910065,NCT02293395,NCT00335452,NCT01294462,NCT05233124,NCT02120092,NCT02034292,NCT01755520
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
NCT01790997,NCT02869009,NCT00417898,NCT01800357,NCT04809818,NCT00265408,NCT00061373,NCT03219645,NCT01675115,NCT02071004,NCT04142125,NCT01831011
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04324463,NCT04498273,NCT04368377,NCT04466670,NCT04343001,NCT04937088,NCT04365309,NCT05073718,NCT02735707,NCT04410328,NCT04554433,NCT04363840
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
NCT01890005,NCT03667326,NCT02007837,NCT02174328,NCT02301780,NCT02797249,NCT04645004,NCT04070573,NCT04402385,NCT04243278
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
PDE4D
|
Inflammatory spondyloarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92 |
PTGS1
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
PDE4D
|
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
PTGS1
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PTGS1
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
PTGS1
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
PTGS1
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
PDE4D
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
PTGS1
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTGS1
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PTGS1
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
PTGS1
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
PDE4D
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
PTAFR
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
PTGS1
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
PTGS1
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
PTGS1
|
Urinary system diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC2Z |
PTGS1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
PTGS1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Ataxic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03 |
PTGS1
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
PTAFR
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
PTGS1
|
Dengue feverDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
PTAFR
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
PTGS1
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
PTGS1
|
Reactive arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA11 |
PTGS1
|
Inherited coagulation factor deficiencyDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B14 |
PTGS1
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
PTGS1
|
Joint painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
PTGS1
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
PDE4D
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
NCT02126657
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT04284397
|
Disseminated intravascular coagulationDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B20 |
NCT04363840
|
Duodenal ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA63 |
NCT01646814
|
Herpes simplex labialisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00.01 |
NCT01985321
|
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT04160546
|
OsteonecrosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB81 |
NCT03405974
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT01936233
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT03192059
|
Injury of lung, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NB32.3Z |
NCT01659307
|
Cerebrovascular diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B22-8B2Z |
NCT00000479
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT01635426
|
Acute non-ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.1 |
NCT03541109
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NCT04214990
|
Cutaneous lupus erythematosusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EB50-EB5Z |
NCT01352988
|
NasopharyngitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA00 |
NCT01453400
|
Hypertrophic cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.1 |
NCT02674958
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT01028079
|
Maternal care for fetal growth restrictionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA86.4 |
NCT01616615
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT00587496
|
Transient ischaemic attackDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10 |
NCT00235248
|
LeukoplakiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.00 |
NCT01238185
|
ulcer diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61-DA63.Y |
NCT00688428
|
Postherpetic polyneuropathyDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E91.5 |
NCT00566904
|
Gastrointestinal bleeding, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME24.9Z |
NCT00557921
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NCT00000151
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT02420652
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT03170115
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT02047539
|
Blood-forming organ diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT04363840
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT02602938
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT04368377
|
Diabetic polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C03.0 |
NCT04649203
|
Late effects of cerebral ischemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B25.0 |
NCT00235248
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01707823
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01496521
|
Fracture of unspecified body regionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56.2 |
NCT03765619
|
FatigueDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG22 |
NCT03051646
|
Respiratory failureDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB41 |
NCT04368377
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NCT03152409
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
NCT05428072
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
NCT02735707
|
Chronic rheumatic heart diseases, not elsewhere classifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC20 |
NCT02832531
|
Vitamin D deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B57 |
NCT04363840
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT00300365
|
Malignant neoplasms of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT02659384
|
Single episode depressive disorder, severe, without psychotic symptomsDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70.3 |
NCT03152409
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00486512
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
NCT02268565
|
HypercholesterolaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.0 |
NCT01362218
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT03192059
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
NCT04128956
|
BlindnessDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9D90.6 |
NCT00000151
|
ThrombophiliaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B61 |
NCT01046942
|
Retinal vascular occlusionDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B74 |
NCT00732927
|
HypertriglyceridaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80.1 |
NCT01486433
|
Intrauterine growth restriction, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1Z |
NCT04557475
|
Other chest painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD30.1 |
NCT03820466
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NCT03824938
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT00790452
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT03290820
|
Diseases of the circulatory system, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
NCT00775762
|
AdenomyosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA11 |
NCT04535804
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT03245489
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT00007683
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT00178464
|
Columnar metaplastic epithelium of the oesophagus, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA23.Z |
NCT02521285
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NCT03899987
|
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
NCT01320982
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
BLM
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
BLM
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TSHR
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
PTAFR
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
BLM
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
LMNA
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
PTAFR
|